Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the Academy of Consultation-Liaison Psychiatry|August 26, 2021
A Brexanolone Treatment Program at an Academic Medical Center: Patient Selection, 90-Day Posttreatment Outcomes, and Lessons LearnedRiah Patterson, Holly Krohn, Erin Richardson, et al.
Archives of Women'S Mental Health|September 23, 2022
The longitudinal effects of stress and fear on psychiatric symptoms in mothers during the COVID-19 pandemicAnna E Bauer, Jerry Guintivano, Holly Krohn, et al.
JMIR Formative Research|March 23, 2022
App-Based Ecological Momentary Assessment to Enhance Clinical Care for Postpartum Depression: Pilot Acceptability StudyHolly Krohn, Jerry Guintivano, Rachel Frische, et al.
General Hospital Psychiatry|November 6, 2025
Open-label study of the efficacy, safety and tolerability of Brexanolone in the treatment of adult women with postpartum psychosisRiah Patterson, Holly Krohn, Elizabeth Richardson, et al.
Ebiomedicine|February 21, 2023
Brexanolone therapeutics in post-partum depression involves inhibition of systemic inflammatory pathwaysIrina Balan, Riah Patterson, Giorgia Boero, et al.
Translational Psychiatry|January 31, 2026
Brexanolone infusion produces sustained anti-inflammatory and neurotrophic effects in patients with postpartum depression that predict symptom improvementIrina Balan, Cecilia Isabel Sousa Pearson, Holly Krohn, et al.
Translational Psychiatry|December 1, 2018
PPD ACT: an app-based genetic study of postpartum depressionJerry Guintivano, Holly Krohn, Carol Lewis, et al.
The Lancet. Psychiatry|June 23, 2018
Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studiesTrine Munk-Olsen, Xiaoqin Liu, Alexander Viktorin, et al.
The American Journal of Psychiatry|October 18, 2023
Meta-Analyses of Genome-Wide Association Studies for Postpartum DepressionJerry Guintivano, Enda M Byrne, Jacqueline Kiewa, et al.
Pageof 1